PSMA-PET research: addressing challenges and prospects - Authors' reply

被引：0
|
作者：
Hadaschik, Boris A. [1 ]
Karpinski, Madeleine J. [2 ,3 ,4 ]
Huesing, Johannes [4 ]
Fendler, Wolfgang [2 ,3 ]
机构：
[1] Univ Hosp Essen, Dept Urol, Essen, Germany
[2] DKTK, Dept Nucl Med, D-45147 Essen, Germany
[3] NCT Univ Hosp Essen, D-45147 Essen, Germany
[4] State Canc Registry North Rhine Westphalia, Bochum, Germany
来源：
LANCET ONCOLOGY | 2024年 / 25卷 / 11期
关键词：
D O I：
10.1016/S1470-2045(24)00582-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：e533 / e533
页数：1
相关论文
共 50 条
  • [31] E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET
    Francesco Ceci
    Daniela E. Oprea-Lager
    Louise Emmett
    Judit A. Adam
    Jamshed Bomanji
    Johannes Czernin
    Matthias Eiber
    Uwe Haberkorn
    Michael S. Hofman
    Thomas A. Hope
    Rakesh Kumar
    Steven P. Rowe
    Sarah M. Schwarzenboeck
    Stefano Fanti
    Ken Herrmann
    European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48 : 1626 - 1638
  • [32] Recurrent prostate cancer: combined role for MRI and PSMA-PET in 68Ga-PSMA-11 PET/MRI
    Jannusch, Kai
    Bruckmann, Nils Martin
    Morawitz, Janna
    Boschheidgen, Matthias
    Quick, Harald H.
    Herrmann, Ken
    Fendler, Wolfgang P.
    Umutlu, Lale
    Stuschke, Martin
    Hadaschik, Boris
    Antoch, Gerald
    Schimmoeller, Lars
    Kirchner, Julian
    EUROPEAN RADIOLOGY, 2024, 34 (07) : 4789 - 4800
  • [33] Primary staging with PSMA-PET improves the prediction of prostate cancer recurrence
    Yirga, Leubet
    Hadaschik, Boris
    Puellen, Lukas
    UROLOGIE, 2023, : 1326 - 1327
  • [34] PSMA-PET: is the time to say goodbye to metabolic radiopharmaceuticals in prostate cancer?
    Laura Evangelista
    Pierpaolo Alongi
    European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48 : 1709 - 1711
  • [35] Uncovering multifocality - PSMA-PET radiomic features for detection of intraprostatic microlesions
    Bettermann, A. S.
    Spohn, S.
    Kiefer, S.
    Jilg, C. A.
    Kranz-Rudolph, J.
    Fassbender, T. F.
    Bronsert, P.
    Nicolay, N. H.
    Mix, M.
    Ruf, J.
    Benndorf, M.
    Grosu, A. L.
    Zamboglou, C.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S371 - S372
  • [36] Emotional state of patients with prostate cancer during PSMA-PET/CT
    Boeser, J.
    Faller, H.
    Lukasczik, M.
    Weisbrodt, J.
    Werner, R. A.
    Buck, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S692 - S692
  • [37] The novel PROMISE framework for PSMA-PET reporting: ready for the clinical routine?
    Seifert, Robert
    Eiber, Matthias
    Herrmann, Ken
    Hadaschik, Boris
    Fendler, Wolfgang Peter
    CLINICAL AND TRANSLATIONAL IMAGING, 2024, 12 (01) : 1 - 3
  • [38] Influence of PSMA-PET on treatment of prostate cancer patients with biochemical recurrence
    Knudtsen, I. S.
    Abrahamsen, B. S.
    Selnaes, K. M.
    Elschot, M.
    Langorgen, S.
    Keil, T. M.
    Johansen, H.
    Bertilsson, H.
    Tandstad, T.
    Bathen, T. F.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S1189 - S1190
  • [39] PSMA-PET: is the time to say goodbye to metabolic radiopharmaceuticals in prostate cancer?
    Evangelista, Laura
    Alongi, Pierpaolo
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (06) : 1709 - 1711
  • [40] PSMA-PET: is there something we can do to facilitate the interpretation of the image?
    Betech-Antar, V.
    Guillen, E.
    Rosales, J.
    Minguez, F.
    Romera, M.
    Bronte, A.
    del Rio, F. Pareja
    Perez-Gracia, J.
    Martinez-Monge, R.
    Minana, B.
    Rodriguez-Fraile, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S554 - S554
12345